Page 429 - شرور شركات الأدوية

‫ﻣﻼﺣﻈﺎت‬

(46) Van Winkelen P, van Denderen JS, Vossen CY, Huizinga TWJ,
Dekker FW, for the SEDUCE study group. How evidence-based are ad-
vertisements in journals regarding the subspecialty of rheumatology?
Rheumatology. 2006 Sep 1;45(9):1154–7.

(47) Othman N, Vitry A, Roughead EE. Quality of Pharmaceutical Ad-
vertisements in Medical Journals: A Systematic Review. PLoS ONE. 2009 Jul
22;4(7):e6350.

(48) Gibson L. UK government fails to tackle weaknesses in drug in-
dustry. BMJ. 2005 Sep 10;331(7516):534–40.

(49) Wilkes MS, Kravitz RL. Policies, practices, and attitudes of North
American medical journal editors. J Gen Intern Med. 1995 Aug;10(8):443–
50.

(50) Via: Cooper RJ, Schriger DL, Wallace RC, Mikulich VJ, Wilkes MS.
The Quantity and Quality of Scientific Graphs in Pharmaceutical Adver-
tisements. J Gen Intern Med. 2003 Apr;18(4):294–7. ‘Polling of the audi-
ence occurred as part of the discussion of the oral presentation of this ab-
stract’. FOURTH INTERNATIONAL CONGRESS ON PEER REVIEW [Internet].
Available from: http://www.ama-assn.org/public/peer/prc_program2001
.htm#ABSTRACTS.

(51) You might also enjoy some of the books written by retired drug
reps, such as: Reidy J. Hard Sell: The Evolution of a Viagra Salesman. 1st
ed. Andrews McMeel Publishing; 2005.

(52) Rockoff JD. Drug Reps Soften Their Sales Pitches. Wall Street
Journal [Internet]. 2012 Jan 10 [cited 2012 Mar 22]; Available from:
http://online.wsj.com/article/SB1000142405297020433130457714276
3014776148.html.

(53) Fugh-Berman A, Ahari S. Following the Script: How Drug Reps
Make Friends and Influence Doctors. PLoS Med. 2007 Apr;4(4).

429